NAGA, also known as alpha-N-acetylgalactosaminidase, is a lysosomal exoglycosidase that cleaves terminal alpha-N-acetylgalactosamine residues from glycopeptides and glycolipids. It is hardly expected to cause an allergic reaction in Fabry disease patients. It is highly promising as a new and safe enzyme for ERT for Fabry disease.
Source:Recombinant protein corresponding to aa18-411 from human NAGA, fused to His-Tag at C-terminal, expressed in insect cell.
Molecular Weight:~45.5kD (400aa) 40-57kD (SDS-PAGE under reducing conditions
Endotoxin:~1EU/1ug (LAL)
Storage and Stability:May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
Size:20ug
Source Antigen:Recombinant, human from insect cell line
Grade:Highly Purified
Purity:~90% (SDS-PAGE)
Form:Supplied as a liquid in PBS, pH 7.4, 10% glycerol.